Generali Investments CEE investicni spolecnost a.s. Invests $2.24 Million in Colgate-Palmolive (NYSE:CL)

Generali Investments CEE investicni spolecnost a.s. purchased a new stake in Colgate-Palmolive (NYSE:CL - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 24,600 shares of the company's stock, valued at approximately $2,236,000.

Several other institutional investors have also recently made changes to their positions in the stock. Kohmann Bosshard Financial Services LLC bought a new stake in Colgate-Palmolive in the 4th quarter valued at about $26,000. Centricity Wealth Management LLC acquired a new stake in Colgate-Palmolive in the fourth quarter valued at approximately $27,000. Union Bancaire Privee UBP SA bought a new stake in shares of Colgate-Palmolive during the fourth quarter valued at approximately $32,000. Bernard Wealth Management Corp. acquired a new position in shares of Colgate-Palmolive during the fourth quarter worth approximately $36,000. Finally, Roxbury Financial LLC acquired a new stake in Colgate-Palmolive in the 4th quarter valued at $43,000. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Stock Down 2.8 %

Colgate-Palmolive stock traded down $2.76 during trading hours on Tuesday, hitting $94.74. 1,694,091 shares of the stock traded hands, compared to its average volume of 4,144,697. Colgate-Palmolive has a one year low of $85.32 and a one year high of $109.30. The firm's 50-day moving average price is $88.97 and its two-hundred day moving average price is $95.06. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The company has a market cap of $76.88 billion, a PE ratio of 26.95, a PEG ratio of 4.20 and a beta of 0.40.

Remove Ads

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter last year, the firm earned $0.87 EPS. On average, research analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 2.11%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive's dividend payout ratio (DPR) is presently 56.82%.

Analyst Ratings Changes

Several analysts have recently commented on the company. Piper Sandler lowered their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating for the company in a research note on Monday, January 6th. Raymond James reiterated an "outperform" rating and issued a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. StockNews.com raised shares of Colgate-Palmolive from a "hold" rating to a "buy" rating in a research report on Monday, March 3rd. Stifel Nicolaus reduced their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating for the company in a research report on Monday, February 3rd. Finally, TD Cowen dropped their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating on the stock in a research report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have issued a buy rating to the company's stock. According to data from MarketBeat, Colgate-Palmolive presently has an average rating of "Moderate Buy" and an average price target of $101.61.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.